Tops & Flops Stocks
Security | Change (%) ▲ | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Immucell Corp | -2.530% | -1.702% | -2.532% | 2.667% | 4.525% | -48.950% | -12.351% |
Evoke Pharma Inc. | -2.400% | 6.842% | -26.847% | -76.118% | -57.037% | -97.486% | -94.629% |
Cyclacel Pharmaceuticals Inc. | -2.260% | - | - | - | - | - | - |
Dare Bioscience Inc. | -2.230% | 2.116% | -37.540% | -68.117% | -2.196% | -76.502% | - |
Qualigen Therapeutics Inc. | -2.110% | - | - | - | - | - | - |
JCR Pharmaceuticals Co Ltd | -1.890% | - | - | - | - | - | - |
Hisamitsu Pharmaceutical | -1.800% | -0.909% | -5.217% | -10.656% | -18.657% | -53.617% | -40.664% |
Nuvo Pharmaceuticals Inc. | -1.640% | - | - | - | - | - | - |
Kissei Pharmaceutical Co Ltd | -1.630% | - | - | - | - | - | - |
Knight Therapeutics | -1.520% | 1.571% | 9.605% | 26.797% | 10.227% | 7.778% | -18.522% |
BELLUS Health Inc. | -1.490% | - | - | - | - | - | - |
GNI Group Ltd | -1.380% | -2.055% | -16.374% | 116.667% | -18.750% | -4.667% | 81.548% |
aTyr Pharma Inc | -1.370% | -0.690% | -13.253% | -20.442% | 11.628% | -56.627% | -79.429% |
Gensight Biologics SA | -1.320% | -6.407% | -3.995% | -29.849% | -15.914% | -95.909% | -78.811% |
Sirona Biochem Corp. | -1.190% | 0.000% | -5.435% | -54.017% | -33.077% | -81.250% | -73.952% |
Biotec Pharmacon ASA | -1.170% | -2.759% | -12.963% | -31.664% | -41.250% | -80.755% | 400.000% |
AC Immune Ltd | -1.100% | 0.913% | -15.326% | 31.704% | -49.543% | -58.807% | - |
Lisata Therapeutics Inc. | -0.820% | -1.626% | -12.950% | -12.950% | -3.968% | -87.960% | -93.613% |
Pt Tempo Scan Rp 50 | -0.720% | - | - | - | - | - | - |
Cidara Therapeutics Inc | -0.620% | - | - | - | - | - | - |
IVERIC bio Inc. | -0.550% | - | - | - | - | - | - |
Acerus Pharmaceuticals Corp. | -0.510% | - | - | - | - | - | - |
Genoway S.A. Inh. | -0.250% | 1.292% | -2.000% | 3.979% | -11.111% | 19.695% | 115.978% |
GenKyoTex S.A. | 0.160% | - | - | - | - | - | - |
Ose Pharma International S.A. | 0.480% | 10.498% | 19.423% | 67.838% | 41.943% | - | - |